Increased Responses to the Actions of Fibroblast Growth Factor 21 on Energy Balance and Body Weight in a Seasonal Model of Adiposity

Journal of Neuroendocrinology

Volumn 25, Issue 2, 2013, Pages 180-189

  Murphy, M ^a,b   Samms, R ^a   Warner, A ^a,b   Bolborea, M ^a,c   Barrett, P ^c   Fowler, M J ^a   Brameld, J M ^b   Tsintzas, K ^a   Kharitonenkov, A ^d   Adams, A C ^d   Coskun, T ^d   Ebling, F J P ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Appetite; Energy expenditure; Metabolic rate; Photoperiod

Indexed keywords

ANTIOBESITY AGENT; CARBON DIOXIDE; OXYGEN; RECOMBINANT FIBROBLAST GROWTH FACTOR 21; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; BODY WEIGHT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; HAMSTER; LOCOMOTION; LUNG GAS EXCHANGE; MALE; METABOLIC PARAMETERS; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; THERAPY EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPOSITY; ANIMALS; BODY WEIGHT; CRICETINAE; EATING; ENERGY METABOLISM; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; HOMEOSTASIS; HYPOTHALAMUS; MALE; MODELS, ANIMAL; OVERWEIGHT; PHODOPUS; PHOTOPERIOD; SEASONS;

EID: 84873040644     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02383.x     Document Type: Article

References (47)

1. Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 2000; 1492: 203-206.
2. Kharitonenkov A. FGFs and metabolism. Curr Opin Pharmacol 2009; 9: 805-810.
3. Kharitonenkov A, Larsen PJ. FGF21 reloaded: challenges of a rapidly growing field. Trends Endocrinol Metab 2010; 22: 81-86.
4. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB. FGF-21 as a novel metabolic regulator. J Clin Invest 2005; 115: 1627-1635.
5. Kharitonenkov A, Shanafelt AB. FGF21: a novel prospect for the treatment of metabolic diseases. Curr Opin Investig Drugs 2009; 10: 359-364.
6. Dostálová I, Haluzíková D, Haluzík M. Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus. Physiol Res 2010; 58: 1-7.
7. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier J, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 2007; 5: 426-437.
8. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ, Kliewer SA. Endocrine regulation of the fasting response by PPAR+|- mediated induction of fibroblast growth factor 21. Cell Metab 2007; 5: 415-425.
9. Christodoulides C, Dyson P, Sprecher D, Tsintzas K, Karpe F. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. J Clin Endocrinol Metab 2009; 94: 444-447.
10. Galman C, Lundasen T, Kharitonenkov A, Bina HA, Eriksson M, Hafstrom I, Dahlin M, Amark P, Angelin B, Rudling M. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab 2008; 8: 169-174.
11. Hotta Y, Nakamura H, Konishi M, Murata Y, Takagi H, Matsumura S, Inoue K, Fushiki T, Itoh N. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 2009; 150: 4625-4633.
12. Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS, Maratos-Flier E. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010; 59: 2781-2789.
13. Hale C, Chen MM, Stanislaus S, Chinookoswong N, Hager T, Wang M, Veniant MM, Xu J. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance. Endocrinology 2012; 153: 69-80.
14. Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS, Xu A. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008; 57: 1246-1253.
15. Mai K, Schwarz F, Bobbert T, Andres J, Assmann A, Pfeiffer AF, Spranger J. Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction. Metabolism 2010; 60: 306-311.
16. Dostálová I, Kaválková P, Haluzikova D, Lacinova Z, Mraz M, Papezova H, Haluzík M. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J Clin Endocrinol Metab 2008; 93: 3627-3632.
17. Li X, Ge H, Weiszmann J, Hecht R, Li YS, Véniant MM, Xu J, Lindberg R, Li Y. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice. FEBS Lett 2009; 583: 3230-3234.
18. Arner P, Pettersson A, Mitchell PJ, Dunbar JD, Kharitonenkov A, Rydén M. FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity. FEBS Lett 2008; 582: 1725-1730.
19. Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE, Kharitonenkov A. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008; 149: 6018-6027.
20. Morgan PJ, Ross AW, Mercer JG, Barrett P. What can we learn from seasonal animals about the regulation of energy balance? Prog Brain Res 2006; 153: 325-337.
21. Ebling FJP, Barrett P. The regulation of seasonal changes in food intake and body weight. J Neuroendocrinol 2008; 20: 827-833.
22. Reddy AB, Cronin AS, Ford H, Ebling FJP. Seasonal regulation of food intake and body weight in the male Siberian hamster: studies of hypothalamic orexin (hypocretin), neuropeptide Y (NPY) and pro-opiomelanocortin (POMC). Eur J Neurosci 1999; 11: 3255-3264.
23. Ivanova EA, Bechtold DA, Dupre SM, Brennand J, Barrett P, Luckman SM, Loudon ASI. Altered metabolism in the melatonin-related receptor (GPR50) knockout mouse. Am J Physiol 2008; 294: 176-182.
24. Jethwa PH, Warner A, Nilaweera KN, Brameld JM, Keyte JD, Carter WG, Bolton N, Bruggraber M, Morgan PJ, Barrett P, Ebling FJP. A VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters. Endocrinology 2007; 148: 4044-4055.
25. Nilaweera KN, Herwig A, Bolborea M, Campbell G, Mayer CD, Morgan PJ, Ebling FJP, Barrett P. Photoperiodic regulation of glycogen metabolism, glycolysis, and glutamine synthesis in tanycytes of the Siberian hamster suggests novel roles of tanycytes in hypothalamic function. Glia 2011; 59: 1695-1705.
26. Ebling FJP. Photoperiodic differences during development in the dwarf hamsters Phodopus sungorus and Phodopus campbelli. Gen Comp Endocrinol 1994; 95: 475-482.
27. Warner A, Jethwa PH, Wyse CA, I'Anson H, Brameld JM, Ebling FJP. Effects of photoperiod on daily locomotor activity, energy expenditure and feeding behavior in a seasonal mammal. Am J Physiol 2010; 298: R1409-R1416.
28. Barrett P, Ross AW, Balik A, Littlewood PA, Mercer JG, Moar KM, Sallmen T, Schuhler S, Ebling FJP, Ubeaud C, Morgan PJ. Photoperiodic regulation of histamine H3 receptor and VGF mRNA in the arcuate nucleus of the Siberian hamster. Endocrinology 2005; 146: 1930-1939.
29. Barrett P, Ebling FJP, Schuhler S, Wilson D, Ross AW, Warner A, Jethwa PH, Boelen A, Visser TJ, Ozanne DM, Archer ZA, Mercer JG, Morgan PJ. Hypothalamic thyroid hormone catabolism acts as a gatekeeper for the seasonal control of body weight and reproduction. Endocrinology 2007; 148: 3608-3617.
30. Barrett P, Ivanova E, Graham ES, Ross AW, Wilson D, Ple H, Mercer JG, Ebling FJP, Schuhler S, Dupre SM, Loudon ASI, Morgan PJ. Photoperiodic regulation of GPR50, nestin and CRBP1 in tanycytes of the third ventricle ependymal layer of the Siberian hamster. J Endocr 2006; 191: 687-698.
31. Mercer JG, Lawrence CB, Moar KM, Atkinson T, Barrett P. Short-day weight loss and effect of food deprivation on hypothalamic NPY and CRF mRNA in Djungarian hamsters. Am J Physiol 1997; 273: R768-R776.
32. Yang C, Jin C, Li X, Wang F, McKeehan WL, Luo Y. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. PLoS ONE 2012; 7: e33870.
33. Sarruf DA, Thaler JP, Morton GJ, German J, Fischer JD, Ogimoto K, Schwartz MW. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 2010; 59: 1817-1824.
34. Schneider JE. Effects of the fructose analog, 2, 5-anhydro-d-mannitol, on food intake and estrous cyclicity in Syrian hamsters. Am J Physiol 1997; 272: R935-R939.
35. Mercer JG, Moar KM, Logie TJ, Findlay PA, Adam CL, Morgan PJ. Seasonally inappropriate body weight induced by food restriction: effect on hypothalamic gene expression in male Siberian hamsters. Endocrinology 2001; 142: 4173-4181.
36. Hsuchou H, Pan W, Kastin AJ. The fasting polypeptide FGF21 can enter brain from blood. Peptides 2007; 28: 2382-2386.
37. Li SA, Watanabe M, Yamada H, Nagai A, Kinuta M, Takei K. Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct 2004; 29: 91-99.
38. Sun HD, Malabunga M, Tonra JR, DiRenzo R, Carrick FE, Zheng H, Berthoud HR, McGuinness OP, Shen J, Bohlen P, Leibel RL, Kussie P. Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys. Am J Physiol 2007; 292: E964-E976.
39. Rodriguez EM, Blazquez JL, Pastor FE, Pelaez B, Pena P, Peruzzo B, Amat P. Hypothalamic tanycytes: a key component of brain-endocrine interaction. Int Rev Cytol 2005; 247: 89-164.
40. Levin BE, Magnan C, Dunn-Meynell AA, Le Foll C. Metabolic sensing and the brain: who, what, where, and how? Endocrinology 2011; 152: 2552-2557.
41. Frayling C, Britton R, Dale N. ATP-mediated glucosensing by hypothalamic tanycytes. J Physiol 2011; 589: 2275-2286.
42. Murphy M, Jethwa PH, Warner A, Barrett P, Nilaweera KN, Brameld JM, Ebling FJP. Effects of manipulating hypothalamic tri-iodothyronine concentrations on seasonal body weight and torpor cycles in Siberian hamsters. Endocrinology 2012; 153: 101-112.
43. Dushay J, Chui PC, Gopalakrishnan GS, Varela-Rey M, Crawley M, Fisher FM, Badman MK, Martinez-Chantar ML, Maratos-Flier E. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010; 139: 456-463.
44. Heldmaier G, Steinlechner S, Rafael J, Vsiansky P. Photoperiodic control and effects of melatonin on nonshivering thermogenesis and brown adipose tissue. Science 1981; 212: 917-919.
45. Rafael J, Vsiansky P, Heldmaier G. Seasonal adaptation of brown adipose tissue in the Djungarian hamster. J Comp Physiol B 1985; 155: 521-528.
46. Fisher FM, Kleiner S, Fox EC, Mepani RJ, Verdeguer J, Wu J, Kharitonenkov A, Flier JS, Maratos-Flier E, Spiegelman BM. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 2012; 26: 271-281.
47. Rousseau K, Atcha Z, Cagampang FRA, Le Rouzic P, Stirland JA, Ivanov TR, Ebling FJP, Klingenspor M, Loudon ASI. Photoperiodic regulation of leptin resistance in the seasonally breeding Siberian hamster (Phodopus sungorus). Endocrinology 2002; 143: 3083-3095.